Vaidya Sane Ayurved Laboratories Complete Financial Statements
MADHAVBAUG • Review detailed financials to uncover trends, confirm thesis & journal trades
4 Years of Data
2025 - 2022
Complete Financial Data Export
Export complete financial statements for Vaidya Sane Ayurved Laboratories (MADHAVBAUG).
Downloads include all available records across all periods.
Profitability Ratios
Net Profit Margin
4.54%
2023 data
EBITDA Margin
6.42%
2023 data
Operating Margin
5.00%
2023 data
Return on Assets
305.19%
2023 data
Return on Equity
373.02%
2023 data
Balance Sheet Ratios
Current Ratio
10.00
2023 data
Equity Ratio
81.82%
2023 data
Asset Turnover
67.18
2023 data
Year-over-Year Growth Analysis
Comparing Sept 2022 vs Sept 2023
Revenue Growth
-48.5%
Year-over-Year
Net Profit Growth
-75.7%
Year-over-Year
EBITDA Growth
-64.0%
Year-over-Year
Expense Growth
-47.0%
Year-over-Year
Assets Growth
+10.0%
Year-over-Year
Equity Growth
+12.5%
Year-over-Year
Operating Cash Flow Growth
+1200.0%
Year-over-Year
Investing Cash Flow Growth
+23.1%
Year-over-Year
Financing Cash Flow Growth
-106.7%
Year-over-Year
Income Statement
Periods
₹ Crores
| Particulars | Sept 2023 | Jun 2023 | Sept 2022 |
|---|---|---|---|
| Revenue | 5,173 | 4,641 | 10,053 |
| Expenses | 4,842 | 4,142 | 9,131 |
| EBITDA | 332 | 500 | 922 |
| Operating Profit Margin % | 5.00% | 9.00% | 8.00% |
| Depreciation | 159 | 116 | 260 |
| Interest | 16 | 11 | 19 |
| Profit Before Tax | 157 | 373 | 643 |
| Tax | -78 | 126 | -323 |
| Net Profit | 235 | 247 | 967 |
| Earnings Per Share (₹) | 1.12 | 2.60 | 4.60 |
Related Pages for Vaidya Sane Ayurved Laboratories
Additional stock information and data for MADHAVBAUG
Balance Sheet
Years
Annual Data
₹ Crores
| Particulars | 2025 | 2024 | 2023 |
|---|---|---|---|
| ASSETS | |||
| Total Assets | 77 | 70 | 55 |
| Current Assets | 30 | 31 | 28 |
| Fixed Assets | 34 | 28 | 21 |
| Capital Work in Progress | 1 | 3 | 2 |
| Investments | 15 | 16 | 14 |
| Other Assets | 27 | 23 | 19 |
| LIABILITIES | |||
| Total Liabilities | |||
| Current Liabilities | 3 | 3 | 2 |
| Non-Current Liabilities | |||
| SHAREHOLDERS' EQUITY | |||
| Total Equity | 63 | 56 | 41 |
| Share Capital | 11 | 11 | 11 |
| Reserves & Surplus | 52 | 32 | 30 |
Cash Flow Statement
Periods
₹ Crores
| Particulars | March 2025 | March 2024 | March 2023 |
|---|---|---|---|
| Operating Activities | 11 | -1 | 0 |
| Investing Activities | -10 | -13 | 1 |
| Financing Activities | -1 | 15 | -1 |
| Net Cash Flow | 0 | 1 | -1 |